U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C29H30F3N2O5P
Molecular Weight 574.5279
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FOSDAGROCORAT

SMILES

[H][C@]12CCC3=C(C=CC(=C3)C(=O)NC4=CC=CN=C4C)[C@]1(CC5=CC=CC=C5)CC[C@](C2)(OP(O)(O)=O)C(F)(F)F

InChI

InChIKey=BVXLAHSJXXSWFF-KEKPKEOLSA-N
InChI=1S/C29H30F3N2O5P/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(29(30,31)32,39-40(36,37)38)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23H,9,11,13-14,17-18H2,1H3,(H,34,35)(H2,36,37,38)/t23-,27+,28-/m1/s1

HIDE SMILES / InChI
Pfizer developed fosdagrocorat (PF-04171327), a dissociated agonist of the glucocorticoid receptor for the treatment of rheumatoid arthritis. The drug successfully completed the phase II clinical trial; however, further study of the drug was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Pharmacokinetics and food-effect of fosdagrocorat (PF-04171327), a dissociated agonist of the glucocorticoid receptor, in healthy adult Caucasian and Japanese subjects
.
2016 Dec
Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.
2017 Aug
Population Pharmacokinetics of Fosdagrocorat (PF-04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis.
2018 Jan
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study.
2019
Patents
Name Type Language
FOSDAGROCORAT
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
(2R,4aS,10aR)-4a-Benzyl-7-[(2-methylpyridin-3-yl)carbamoyl]-2-(trifluoromethyl)-1,2,3,4,4a,9,10,10a-octahydrophenanthren-2-yl dihydrogen phosphate
Systematic Name English
2-PHENANTHRENECARBOXAMIDE, 4B,5,6,7,8,8A,9,10-OCTAHYDRO-N-(2-METHYL-3-PYRIDINYL)-4B-(PHENYLMETHYL)-7-(PHOSPHONOOXY)-7-(TRIFLUOROMETHYL)-, (4BS,7R,8AR)-
Systematic Name English
PF-04171327
Code English
FOSDAGROCORAT [USAN]
Common Name English
fosdagrocorat [INN]
Common Name English
Fosdagrocorat [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
HPI19004QS
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
ChEMBL
CHEMBL3137316
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
PUBCHEM
24872952
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
USAN
AB-24
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
WIKIPEDIA
Fosdagrocorat
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
SMS_ID
300000034192
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
CAS
1044535-58-1
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
INN
9929
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
DRUG BANK
DB12198
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
EPA CompTox
DTXSID301100531
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY
NCI_THESAURUS
C170007
Created by admin on Sat Dec 16 01:53:21 GMT 2023 , Edited by admin on Sat Dec 16 01:53:21 GMT 2023
PRIMARY